Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Carbazitaxel injection and preparation method thereof

A cabazitaxel and injection technology, which is applied in the field of medicine, can solve the problems of difficult filtration and filling processes, difficult dispersing and dissolving of raw materials, complicated use steps, etc., and achieves the effects of drug-free time limit, long stability time and simple use method.

Active Publication Date: 2020-02-28
KINDOS PHARM CO LTD +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] 1) The solvent polysorbate 80 is a viscous liquid. If the raw material of cabazitaxel is directly added to polysorbate 80, the raw material is not easy to disperse and dissolve, and the filtration and filling process is difficult, which will easily cause loss of raw material
[0004] 2) Two-step dilution is required before clinical use, the use steps are cumbersome, and there is a time limit for medication, which poses a safety hazard
However, the product prescriptions involved in the above-mentioned patents all introduce H + The stabilizer citric acid, which promotes the risk of ring-opening degradation of the ester group and epoxy group in the cabazitaxel molecule, and the product formulation design itself has a stability risk; the application of freeze-drying technology, the product production cycle is long and the cost is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carbazitaxel injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A cabazitaxel injection comprises the following components by mass: 10 parts of cabazitaxel, 200 parts of polysorbate 80, 400 parts of polyethylene glycol and 390 parts of ethanol.

[0026] The molecular weight of the polyethylene glycol is 700.

Embodiment 2

[0028] A cabazitaxel injection comprises the following components by mass: 10 parts of cabazitaxel, 270 parts of polysorbate 80, 500 parts of polyethylene glycol and 220 parts of ethanol.

[0029] The molecular weight of the polyethylene glycol is 800.

Embodiment 3

[0031] A cabazitaxel injection comprises the following components by mass: 10 parts of cabazitaxel, 230 parts of polysorbate 80, 450 parts of polyethylene glycol and 310 parts of ethanol.

[0032] The molecular weight of the polyethylene glycol is 500.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a cabazitaxel injection. The cabazitaxel injection comprises the following components in parts by mass: 10 parts of cabazitaxel, 200-270 parts of polysorbate 80, 400-500 parts of polyethylene glycol and 1,000 parts of ethanol. The product is good in stability, easy to filter and fill, and convenient to use in clinic.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a cabazitaxel injection. Background technique [0002] Cabazitaxel is a second-line chemotherapy drug for the treatment of prostate cancer recommended by the NCCN guidelines in the United States, and it is a chemical semi-synthetic taxane-like small molecule compound. The currently marketed Cabazitaxel injection is a liquid injection. According to the FDA Orange Book, the original manufacturer is Sanofi-aventis U.S. LLC. This product is packaged in combination, one bottle is 60mg / 1.5mL cabazitaxel-polysorbate 80 solution; one bottle is diluent, 13% ethanol-water. Before clinical use, dilute the cabazitaxel solution with 13% ethanol-water. After dilution, the drug solution needs to be diluted in the second step within 30 minutes, otherwise precipitation will occur. There are the following defects: [0003] 1) The solvent polysorbate 80 is a viscous liquid. If the raw material ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K47/10A61K47/26A61K31/337A61P35/00
CPCA61K9/0019A61K9/08A61K31/337A61K47/10A61K47/26A61P35/00
Inventor 李娜李囿林史宣宇田欣欣
Owner KINDOS PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com